Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
42.32
+0.53 (1.27%)
At close: Aug 4, 2026, 4:00 PM EDT
42.33
+0.01 (0.02%)
After-hours: Aug 4, 2026, 7:22 PM EDT
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $68 | Buy | Initiates | $68 | +60.68% | Jul 27, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $48 → $73 | Buy | Reiterates | $48 → $73 | +72.50% | Jul 24, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $63 | Buy | Reiterates | $63 | +48.87% | Jul 15, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $30 → $60 | Buy | Reiterates | $30 → $60 | +41.78% | Jul 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $60 → $58 | Buy | Reiterates | $60 → $58 | +37.05% | Jun 30, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +18.15% | Jun 23, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $61 → $74 | Buy | Reiterates | $61 → $74 | +74.86% | Jun 23, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $37 → $57 | Buy | Maintains | $37 → $57 | +34.69% | Jun 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.